Sara
Labiano Almiñana
Investigadora
Ana
Patiño García
Consultora Investigadora
Publicaciones en las que colabora con Ana Patiño García (10)
2024
-
Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models
JCI Insight, Vol. 9, Núm. 18
-
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models
Neuro-Oncology, Vol. 26, Núm. 8, pp. 1509-1525
2023
-
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
Cancer Cell, Vol. 41, Núm. 11, pp. 1911-1926.e8
2022
-
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
JCI Insight, Vol. 7, Núm. 7
-
Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma
Molecular Therapy - Oncolytics, Vol. 26, pp. 246-264
-
Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory
Molecular Cancer Therapeutics, Vol. 21, Núm. 3, pp. 471-480
-
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
New England Journal of Medicine, Vol. 386, Núm. 26, pp. 2471-2481
2021
-
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 7
-
Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET
Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820
-
Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma
Molecular Therapy - Oncolytics, Vol. 20, pp. 23-33